Clinical Trials Browser

Active not recruiting × Neoplasm Metastasis × Abiraterone Acetate × Clear all

NCT02415621 2025-12-04

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT06193993 2024-01-08

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Phase 1 Active not recruiting

Neoplasm Metastasis, Prostatic Neoplasms